Hc and Fenofibrate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Hc (hydrocortisone) and Fenofibrate (fenofibrate). Common drug interactions include fatigue among females and muscle spasms among males.
The phase IV clinical study analyzes what interactions people have when they take Hc and Fenofibrate. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Hc?
Hc has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 1,369 Hc users. Check the latest studies of Hc.
What is Fenofibrate?
Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.
26 people who take Hc and Fenofibrate together, and have interactions are studied.

What are the common drug interactions of Hc and Fenofibrate, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Nausea (feeling of having an urge to vomit)
- Pain in extremity
- Photopsia (presence of perceived flashes of light)
- Swelling
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
- Tooth abscess (pus formation in tooth)
- Arthralgia (joint pain)
- Carotid bruit (sound heard over the carotid artery area during auscultation)
male:
- Muscle spasms (muscle contraction)
- Blood potassium increased
- Myopathy (a muscular disease in which the muscle fibres do not function)
- Nausea (feeling of having an urge to vomit)
- Rash generalised (rash on most of body parts)
- Vomiting
- Abdominal distension
- Abdominal pain upper
- Asthenia (weakness)
- Back pain
What are the common drug interactions of Hc and Fenofibrate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
40-49:
- Blood potassium increased
- Dysstasia (difficulty in standing)
- Hospitalisation
- Tremor (trembling or shaking movements in one or more parts of your body)
- Malaise (a feeling of general discomfort or uneasiness)
- Muscle spasms (muscle contraction)
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Death
50-59:
- Abdominal distension
- Abdominal pain upper
- Asthenia (weakness)
- Back pain
- Constipation
- Dry skin
- Dyspepsia (indigestion)
- Fatigue (feeling of tiredness)
- Pancreatitis (inflammation of pancreas)
- Bradycardia (abnormally slow heart action)
60+:
- Arthralgia (joint pain)
- Muscular weakness (muscle weakness)
- Carotid bruit (sound heard over the carotid artery area during auscultation)
- Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
- Death
- Dyspnoea (difficult or laboured respiration)
- Fall
- Fatigue (feeling of tiredness)
- Food allergy
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
What are the existing conditions these people have? *
- Hyperkalemia (damage to or disease of the kidney): 4 people, 15.38%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 11.54%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
- Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 3 people, 11.54%
- Stress And Anxiety: 2 people, 7.69%
- Rectal Cancer (cancer of rectum): 2 people, 7.69%
- Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 7.69%
- Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 7.69%
- Immunodeficiency Disorders: 2 people, 7.69%
- Haemorrhoids (a swollen vein or group of veins in the region of the anus): 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Hc and Fenofibrate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Hc (1,369 reports)
- Fenofibrate (40,457 reports)
Browse all drug interactions of Hc and Fenofibrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Hc:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fenofibrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hc and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fenofibrate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on hydrocortisone and fenofibrate (the active ingredients of Hc and Fenofibrate, respectively), and Hc and Fenofibrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Entresto and Thrombocytopenia for Women aged 50-59 - 5 seconds ago
- Entresto and Low Platelet Count for Women aged 50-59 - 6 seconds ago
- Entresto and Platelet Count Decreased for Women aged 50-59 - 6 seconds ago
- Entresto and Thin Blood for Women aged 50-59 - 6 seconds ago
- Entresto and Low Blood Platelet Count for Women aged 50-59 - 6 seconds ago
- Divalproex and Osteopenia for Men aged 50-59 - 20 seconds ago
- Could Cosentyx cause Jaundice - Yellow Skin? - 21 seconds ago
- Ocrevus and Urinary Retention for Women aged 40-49 - 22 seconds ago
- Drug interactions of Fioricet and Bactrim - 33 seconds ago
- Could Busulfan cause Enterococcal Infection? - 34 seconds ago